Microaggression toward LGBTIQ people and implications for mental health: A systematic review.

LGBTIQ alcohol abuse depression mental health microaggressions suicide

Journal

The International journal of social psychiatry
ISSN: 1741-2854
Titre abrégé: Int J Soc Psychiatry
Pays: England
ID NLM: 0374726

Informations de publication

Date de publication:
28 Aug 2023
Historique:
medline: 28 8 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: aheadofprint

Résumé

Research suggests that microaggressions detrimentally impact the mental health of members of marginalized social groups. The aim of this systematic review was to assess the exposure to microaggressions and related implications on mental health of Lesbian, Gay, Bisexual, Transgender, Intersex, and Queer (LGBTIQ) people. Medline, Scopus, PsycINFO, CINAHL, and EMBASE were searched until January 2023. Studies reporting data on the exposure to microaggressions toward LGBTIQ people were identified. Meta-analyses of rates of exposure to microaggression and of the association between microaggressions and mental health outcomes were based on odds ratio (OR) and standardized mean difference (SMD) with 95% confidence intervals (95% CI), estimated through inverse variance models with random effects. The review process led to the selection of 17 studies, involving a total of 9036 LGBTIQ people, of which 6827 identifying as cisgenders, and 492 as heterosexuals, were included in the quantitative synthesis. Overall, LGBTIQ people showed an increased risk of microaggression (SMD: 0.89; 95% CI [0.28, 1.50]), with Transgender people having the highest risk ( LGBTIQ people are at higher risk of microaggressions compared with their cisgender/heterosexual peers, which may lead to mental health consequences. This evidence may contribute to public awareness of LGBTIQ mental health needs and suggest supportive strategies as well as preventive interventions (e.g., supportive programs and destigmatizing efforts) as parts of tailored health-care planning aimed to reduce psychiatric morbidity in this population.

Sections du résumé

BACKGROUND UNASSIGNED
Research suggests that microaggressions detrimentally impact the mental health of members of marginalized social groups.
AIMS UNASSIGNED
The aim of this systematic review was to assess the exposure to microaggressions and related implications on mental health of Lesbian, Gay, Bisexual, Transgender, Intersex, and Queer (LGBTIQ) people.
METHOD UNASSIGNED
Medline, Scopus, PsycINFO, CINAHL, and EMBASE were searched until January 2023. Studies reporting data on the exposure to microaggressions toward LGBTIQ people were identified. Meta-analyses of rates of exposure to microaggression and of the association between microaggressions and mental health outcomes were based on odds ratio (OR) and standardized mean difference (SMD) with 95% confidence intervals (95% CI), estimated through inverse variance models with random effects.
RESULTS UNASSIGNED
The review process led to the selection of 17 studies, involving a total of 9036 LGBTIQ people, of which 6827 identifying as cisgenders, and 492 as heterosexuals, were included in the quantitative synthesis. Overall, LGBTIQ people showed an increased risk of microaggression (SMD: 0.89; 95% CI [0.28, 1.50]), with Transgender people having the highest risk (
CONCLUSIONS UNASSIGNED
LGBTIQ people are at higher risk of microaggressions compared with their cisgender/heterosexual peers, which may lead to mental health consequences. This evidence may contribute to public awareness of LGBTIQ mental health needs and suggest supportive strategies as well as preventive interventions (e.g., supportive programs and destigmatizing efforts) as parts of tailored health-care planning aimed to reduce psychiatric morbidity in this population.

Identifiants

pubmed: 37638668
doi: 10.1177/00207640231194478
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

207640231194478

Auteurs

Mattia Marchi (M)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Dipartimento ad Attività Integrata di Salute Mentale e Dipendenze Patologiche, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Antonio Travascio (A)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Daniele Uberti (D)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Edoardo De Micheli (E)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Fabio Quartaroli (F)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Giuseppe Laquatra (G)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Pietro Grenzi (P)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Luca Pingani (L)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Dipartimento ad Attività Integrata di Salute Mentale e Dipendenze Patologiche, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Silvia Ferrari (S)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Dipartimento ad Attività Integrata di Salute Mentale e Dipendenze Patologiche, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Andrea Fiorillo (A)

Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy.

Manlio Converti (M)

ASL Napoli 2 Nord, Naples, Italy.

Federica Pinna (F)

Dipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari, Cagliari, Italy.

Francesco Amaddeo (F)

Department of Neurosciences, Biomedicine and Movement, University of Verona, Verona, Italy.

Antonio Ventriglio (A)

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Massimo Mirandola (M)

WHO Collaborating Centre for Sexual Health and Vulnerable Populations, Epidemiology Unit - Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
School of Health Sciences, University of Brighton, Brighton, UK.

Gian M Galeazzi (GM)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Dipartimento ad Attività Integrata di Salute Mentale e Dipendenze Patologiche, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Classifications MeSH